Stocks Comparison
Colgate Palmolive vs Estee Lauder Companies: revenue, profit, margins and growth compared
Colgate Palmolive brought in $20.4B of revenue in fiscal 2025, Estee Lauder Companies $15B in fiscal 2026. Revenue changed by +1.4% at Colgate Palmolive and +5.0% at Estee Lauder Companies on the year before, so Estee Lauder Companies grew faster. Colgate Palmolive kept 10.5% of its revenue as net profit, Estee Lauder Companies 1.2%. Free cash flow was $3.6B at Colgate Palmolive and $1.3B at Estee Lauder Companies.
Side by side, latest fiscal year
| CL | EL | |
|---|---|---|
| Fiscal year ended | FY2025 (December 31, 2025) | FY2026 (June 30, 2026) |
| Revenue | $20.4B | $15B |
| Revenue growth | +1.4% | +5.0% |
| Net income | $2.1B | $182M |
| Net margin | 10.5% | 1.2% |
| Free cash flow | $3.6B | $1.3B |
| Free cash flow margin | 17.8% | 8.7% |
| Earnings per share (diluted) | $2.63 | $0.50 |
| Cash | $1.3B | $3.5B |
| Debt | $7.8B | $6.8B |
| Price to earnings | 32.7 | 188.9 |
| Market value | $68.6B | $34.2B |
| Dividend yield | 2.42% | 1.48% |
| Rank by revenue in sector | #58 of 778 · Consumer discretionary | #88 of 778 · Consumer discretionary |
Over the years
Questions about Colgate Palmolive and Estee Lauder Companies
Which is bigger by revenue, Colgate Palmolive or Estee Lauder Companies?
Colgate Palmolive is bigger by revenue: $20.4B in fiscal 2025, against $15B for Estee Lauder Companies in fiscal 2026.
Which keeps more of its revenue as profit, Colgate Palmolive or Estee Lauder Companies?
Colgate Palmolive had a net margin of 10.5% in fiscal 2025; Estee Lauder Companies had 1.2% in fiscal 2026.
Which grew revenue faster, Colgate Palmolive or Estee Lauder Companies?
In their latest fiscal years revenue changed by +1.4% at Colgate Palmolive and +5.0% at Estee Lauder Companies.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.